Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Litx System and Chemotherapy for Colorectal Liver Metastases
NCT00083785Phase 2Completed
- Sponsor
- Light Science Oncology
- Start
- May 2004
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of talaporfin sodium in colorectal cancer (CRC), sponsored by Light Science Oncology. Primary endpoints: Volume of Photodynamic Therapy Necrosis at 60 days and Radius of Photodynamic Therapy Necrosis at 60 days. Started May 2004; status: completed.
02
Drugs
talaporfin sodium
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00083785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00083785.